---
figid: PMC5804377__OMCL2017-5498908.007
figtitle: A model of the proposed mechanism of hederagenin in cisplatin-resistant
  HNC cells
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5804377
filename: OMCL2017-5498908.007.jpg
figlink: /pmc/articles/PMC5804377/figure/fig7/
number: F7
caption: A model of the proposed mechanism of hederagenin in cisplatin-resistant HNC
  cells. Hederagenin selectively induces apoptosis in cancer cells by promoting ROS
  production and GSH depletion via inhibition of the Nrf2-ARE pathway.
papertitle: Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer
  Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway.
reftext: Eun Hye Kim, et al. Oxid Med Cell Longev. 2017;2017:5498908.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9697814
figid_alias: PMC5804377__F7
figtype: Figure
redirect_from: /figures/PMC5804377__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5804377__OMCL2017-5498908.007.html
  '@type': Dataset
  description: A model of the proposed mechanism of hederagenin in cisplatin-resistant
    HNC cells. Hederagenin selectively induces apoptosis in cancer cells by promoting
    ROS production and GSH depletion via inhibition of the Nrf2-ARE pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Debcl
  - p53
  - betaTub60D
  - hth
  - ref(2)P
  - DCTN4-p62
  - Tfb1
  - Nup62
  - Taf6
  - how
  - Keap1
  - cnc
  - BCL2
  - TP53
  - TP63
  - TP73
  - GTF2H1
  - SQSTM1
  - KHDRBS1
  - NUP62
  - DCTN4
  - KEAP1
  - BAX
  - GABPA
  - NFE2L2
---
